vs

Side-by-side financial comparison of BuzzFeed, Inc. (BZFD) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $56.5M, roughly 1.5× BuzzFeed, Inc.). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -47.4%, a 9.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 0.6%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 23.6%).

BuzzFeed, Inc. is an American Internet media, news, and entertainment company with a focus on digital media. Based in New York City, BuzzFeed was founded in 2006 by Jonah Peretti and John S. Johnson III to focus on tracking viral content. Kenneth Lerer, co-founder and chairman of The Huffington Post, started as a co-founder and investor in BuzzFeed and is now the executive chairman.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

BZFD vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.5× larger
PRCT
$83.1M
$56.5M
BZFD
Growing faster (revenue YoY)
PRCT
PRCT
+19.6% gap
PRCT
20.2%
0.6%
BZFD
Higher net margin
PRCT
PRCT
9.3% more per $
PRCT
-38.1%
-47.4%
BZFD
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
23.6%
BZFD

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
BZFD
BZFD
PRCT
PRCT
Revenue
$56.5M
$83.1M
Net Profit
$-26.8M
$-31.6M
Gross Margin
64.9%
Operating Margin
-43.7%
-4.1%
Net Margin
-47.4%
-38.1%
Revenue YoY
0.6%
20.2%
Net Profit YoY
-186.4%
-27.9%
EPS (diluted)
$-0.72
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BZFD
BZFD
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$56.5M
$76.4M
Q3 25
$46.3M
$83.3M
Q2 25
$46.4M
$79.2M
Q1 25
$36.0M
$69.2M
Q4 24
$56.2M
$68.2M
Q3 24
$55.6M
$58.4M
Q2 24
$41.1M
$53.4M
Net Profit
BZFD
BZFD
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-26.8M
$-29.8M
Q3 25
$-7.4M
$-21.4M
Q2 25
$-10.8M
$-19.6M
Q1 25
$-12.7M
$-24.7M
Q4 24
$31.0M
$-18.9M
Q3 24
$2.1M
$-21.0M
Q2 24
$-7.5M
$-25.6M
Gross Margin
BZFD
BZFD
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
BZFD
BZFD
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-43.7%
-40.6%
Q3 25
-12.9%
-27.8%
Q2 25
-7.5%
-28.0%
Q1 25
-38.1%
-39.7%
Q4 24
7.0%
-28.9%
Q3 24
2.8%
-38.4%
Q2 24
-13.6%
-50.3%
Net Margin
BZFD
BZFD
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-47.4%
-39.1%
Q3 25
-16.1%
-25.7%
Q2 25
-23.3%
-24.7%
Q1 25
-35.2%
-35.8%
Q4 24
55.2%
-27.6%
Q3 24
3.8%
-35.9%
Q2 24
-18.2%
-48.0%
EPS (diluted)
BZFD
BZFD
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.72
$-0.54
Q3 25
$-0.20
$-0.38
Q2 25
$-0.28
$-0.35
Q1 25
$-0.33
$-0.45
Q4 24
$0.86
$-0.34
Q3 24
$0.05
$-0.40
Q2 24
$-0.20
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BZFD
BZFD
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$8.5M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$49.4M
$347.7M
Total Assets
$188.1M
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BZFD
BZFD
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$8.5M
$286.5M
Q3 25
$34.3M
$294.3M
Q2 25
$29.7M
$302.7M
Q1 25
$34.3M
$316.2M
Q4 24
$22.4M
$333.7M
Q3 24
$53.7M
$196.8M
Q2 24
$45.5M
$214.1M
Total Debt
BZFD
BZFD
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
BZFD
BZFD
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$49.4M
$365.9M
Q3 25
$75.9M
$380.3M
Q2 25
$81.1M
$385.8M
Q1 25
$93.8M
$389.2M
Q4 24
$104.8M
$402.2M
Q3 24
$71.7M
$241.2M
Q2 24
$67.2M
$251.8M
Total Assets
BZFD
BZFD
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$188.1M
$508.1M
Q3 25
$211.2M
$511.5M
Q2 25
$210.4M
$513.1M
Q1 25
$203.2M
$519.4M
Q4 24
$221.4M
$534.0M
Q3 24
$276.5M
$374.1M
Q2 24
$272.9M
$374.4M
Debt / Equity
BZFD
BZFD
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BZFD
BZFD
PRCT
PRCT
Operating Cash FlowLast quarter
$-11.7M
Free Cash FlowOCF − Capex
$-12.0M
FCF MarginFCF / Revenue
-21.2%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-20.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BZFD
BZFD
PRCT
PRCT
Q1 26
Q4 25
$-11.7M
$-10.3M
Q3 25
$1.7M
$-6.6M
Q2 25
$-10.1M
$-15.0M
Q1 25
$1.3M
$-17.0M
Q4 24
$-4.6M
$-32.4M
Q3 24
$9.6M
$-18.8M
Q2 24
$-12.4M
$-15.7M
Free Cash Flow
BZFD
BZFD
PRCT
PRCT
Q1 26
Q4 25
$-12.0M
$-12.2M
Q3 25
$892.0K
$-9.5M
Q2 25
$-10.5M
$-17.8M
Q1 25
$956.0K
$-18.8M
Q4 24
$-4.7M
$-33.6M
Q3 24
$9.3M
$-19.0M
Q2 24
$-12.5M
$-16.8M
FCF Margin
BZFD
BZFD
PRCT
PRCT
Q1 26
Q4 25
-21.2%
-15.9%
Q3 25
1.9%
-11.4%
Q2 25
-22.7%
-22.5%
Q1 25
2.7%
-27.2%
Q4 24
-8.4%
-49.2%
Q3 24
16.7%
-32.6%
Q2 24
-30.5%
-31.4%
Capex Intensity
BZFD
BZFD
PRCT
PRCT
Q1 26
Q4 25
0.5%
2.4%
Q3 25
1.8%
3.4%
Q2 25
1.0%
3.5%
Q1 25
1.1%
2.7%
Q4 24
0.3%
1.7%
Q3 24
0.5%
0.4%
Q2 24
0.3%
2.0%
Cash Conversion
BZFD
BZFD
PRCT
PRCT
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-0.15×
Q3 24
4.59×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BZFD
BZFD

Advertising$25.6M45%
Commerce And Other$16.3M29%
Content$14.7M26%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons